Short-term exposure to ambient fine particulate matter increases hospitalizations and mortality in COPD: A systematic review and meta-analysis

Chest

Volumn 149, Issue 2, 2016, Pages 447-458

  Li, Man Hui ^a,b   Fan, Li Chao ^a   Mao, Bei ^a,b   Yang, Jia Wei ^a,b   Choi, Augustine M K ^c   Cao, Wei Jun ^a,b   Xu, Jin Fu ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SOOCHOW UNIVERSITY   (China)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Air pollution; COPD; Environmental health; Environmental pollution

Indexed keywords

AIR POLLUTION; AMBIENT AIR; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFOUNDING VARIABLE; DISEASE ASSOCIATION; DISEASE EXACERBATION; EFFECT SIZE; ENVIRONMENTAL EXPOSURE; HOSPITALIZATION; HUMAN; MEDICAL RESEARCH; MORTALITY; PARTICLE SIZE; PARTICULATE MATTER; PRIORITY JOURNAL; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; ADVERSE EFFECTS; CITY; HEALTH; META ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVIVAL RATE; THEORETICAL MODEL; TIME FACTOR; TRENDS;

PARTICULATE MATTER;

CITIES; ENVIRONMENTAL EXPOSURE; GLOBAL HEALTH; HOSPITALIZATION; HUMANS; MODELS, THEORETICAL; PARTICULATE MATTER; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SURVIVAL RATE; TIME FACTORS;

EID: 84958038128     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-0513     Document Type: Article

References (45)

1. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(1):188-207.
2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD website. http://www.goldcopd.org. Updated 2014. Accessed on July 15, 2014.
3. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(9434): 613-620.
4. Buist AS, McBurnie MA, Vollmer WM, et al; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741-750.
5. Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753-760.
6. Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180(1):3-10.
7. Viegi G, Maio S, Pistelli F, Baldacci S, Carrozzi L. Epidemiology of chronic obstructive pulmonary disease: health effects of air pollution. Respirology. 2006;11(5):523-532.
8. Torres-Duque C, Maldonado D, Pérez-Padilla R, Ezzati M, Viegi G; Forum of International Respiratory Studies (FIRS) Task Force on Health Effects of Biomass Exposure. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc. 2008;5(5):577-590.
9. Moolgavkar SH, Luebeck EG, Anderson EL. Air pollution and hospital admissions for respiratory causes in Minneapolis-St. Paul and Birmingham. Epidemiology. 1997;8(4):364-370.
10. Kim H, Kim Y, Hong YC. The lag-effect pattern in the relationship of particulate air pollution to daily mortality in Seoul, Korea. Int J Biometeorol. 2003;48(1):25-30.
11. Slaughter JC, Kim E, Sheppard L, Sullivan JH, Larson TV, Claiborn C. Association between particulate matter and emergency room visits, hospital admissions and mortality in Spokane. Washington. J Expo Anal Environ Epidemiol. 2005;15(2):153-159.
12. Tsai SS, Chang CC, Yang CY. Fine particulate air pollution and hospital admissions for chronic obstructive pulmonary disease: a case-crossover study in Taipei. Int J Environ Res Public Health. 2013;10(11):6015-6026.
13. Ko FW, Tam W, Wong TW, et al. Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong. Thorax. 2007;62(9):780-785.
14. Anderson HR, Bremner SA, Atkinson RW, Harrison RM, Walters S. Particulate matter and daily mortality and hospital admissions in the west midlands conurbation of the United Kingdom: associations with fine and coarse particles, black smoke and sulphate. Occup Environ Med. 2001;58(8):504-510.
15. Belleudi V, Faustini A, Stafoggia M, et al. Impact of fine and ultrafine particles on emergency hospital admissions for cardiac and respiratory diseases. Epidemiology. 2010;21(3):414-423.
16. Schwartz J, Dockery DW, Neas LM. Is daily mortality associated specifically with fine particles? J Air Waste Manag Assoc. 1996;46(10):927-939.
17. Neuberger M, Moshammer H, Rabczenko D. Acute and subacute effects of urban air pollution on cardiopulmonary emergencies and mortality: time series studies in Austrian cities. Int J Environ Res Public Health. 2013;10(10):4728-4751.
18. Kloog I, Nordio F, Zanobetti A, Coull BA, Koutrakis P, Schwartz JD. Short term effects of particle exposure on hospital admissions in the Mid-Atlantic states: a population estimate. PLoS ONE. 2014;9(2):e88578.
19. Santus P, Russo A, Madonini E, et al. How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan. Respir Res. 2012;13:95.
20. Stieb DM, Szyszkowicz M, Rowe BH, Leech JA. Air pollution and emergency department visits for cardiac and respiratory conditions: a multi-city timeseries analysis. Environ Health. 2009;8:25.
21. Dominici F, Peng RD, Bell ML, et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA. 2006;295(10): 1127-1134.
22. Peel JL, Tolbert PE, Klein M, et al. Ambient air pollution and respiratory emergency department visits. Epidemiology. 2005;16(2):164-174.
23. Chen Y, Yang Q, Krewski D, Shi Y, Burnett RT, McGrail K. Influence of relatively low level of particulate air pollution on hospitalization for COPD in elderly people. Inhal Toxicol. 2004;16(1): 21-25.
24. Tsai SS, Chiu HF, Liou SH, Yang CY. Short-term effects of fine particulate air pollution on hospital admissions for respiratory diseases: a case-crossover study in a tropical city. J Toxicol Environ Health A. 2014;77(18): 1091-1101.
25. Valdés A, Zanobetti A, Halonen JI, Cifuentes L, Morata D, Schwartz J. Elemental concentrations of ambient particles and cause specific mortality in Santiago, Chile: a time series study. Environ Health. 2012;11:82.
26. Lepeule J, Laden F, Dockery D, Schwartz J. Chronic exposure to fine particles and mortality: an extended follow-up of the Harvard Six Cities study from 1974 to 2009. Environ Health Perspect. 2012;120(7):965-970.
27. Neuberger M, Rabczenko D, Moshammer H. Extended effects of air pollution on cardiopulmonary mortality in Vienna. Atmos Environ. 2007;41(38): 8549-8556.
28. Samoli E, Stafoggia M, Rodopoulou S, et al; MED-PARTICLES Study group. Which specific causes of death are associated with short term exposure to fine and coarse particles in Southern Europe? Results from the MEDPARTICLES project. Environ Int. 2014;67: 54-61.
29. World Health Organisation. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: World Health Organisation; 1977.
30. World Health Organisation. International Classification of Diseases, Tenth Revision. Geneva, Switzerland: World Health Organisation; 1992.
31. Goldberg MS, Burnett RT, Bailar JC III, et al. The association between daily mortality and ambient air particle pollution in Montreal, Quebec. Nonaccidental mortality. Environ Res. 2001;86(1):12-25.
32. Zhu R, Chen Y, Wu S, Deng F, Liu Y, Yao W. The relationship between particulate matter (PM10) and hospitalizations and mortality of chronic obstructive pulmonary disease: a meta-analysis. COPD. 2013;10(3): 307-315.
33. Song F, Sheldon TA, Sutton AJ, Abrams KR, Jones DR. Methods for exploring heterogeneity in meta-analysis. Eval Health Prof. 2001;24(2):126-151.
34. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
35. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323(7304): 101-105.
36. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012; 380(9859):2163-2196.
37. World Health Organization. Chronic obstructive pulmonary disease (COPD). WHO website. http://www.who.int/mediacentre/factsheets/fs315/en. Accessed July 15, 2014.
38. Wilson WE, Suh HH. Fine particles and coarse particles: concentration relationships relevant to epidemiologic studies. J Air Waste Manag Assoc. 1997;47(12):1238-1249.
39. Pope CA III, Dockery DW. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc. 2006;56(6):709-742.
40. Ghio AJ, Carraway MS, Madden MC. Composition of air pollution particles and oxidative stress in cells, tissues, and living systems. J Toxicol Environ Health B Crit Rev. 2012;15(1): 1-21.
41. MacNee W, Donaldson K. Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD. Eur Respir J Suppl. 2003;40: 47s-51s.
42. 2.5 and daily mortality and hospital admissions: a systematic review and meta-analysis. Thorax. 2014;69(7):660-665.
43. 10 on hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study. Am J Epidemiol. 2006;163(6): 579-588.
44. Schwartz J, Park SK, O'Neill MS, et al. Glutathione-S-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by-environment interaction. Am J Respir Crit Care Med. 2005;172(12):1529-1533.
45. O'Neill MS, Veves A, Zanobetti A, et al. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation. 2005;111(22):2913-2920.